Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | Important COVID-19 findings at ASH 2021

Mikkael Sekeres • 6 Dec 2021
ASH 2021
General

Mikkael Sekeres, MD, MS, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, highlights discussions surrounding COVID-19 to look out for at ASH 2021. Several sessions will focus on various aspects of SARS-CoV-2 infection, vaccination, and outcomes in hematological patients. Dr Sekeres calls attention to the scientific symposium on COVID vaccination, as well as the ‘ASH Advances COVID Research 2021’ session which will spotlight the most significant abstracts focused on COVID-19. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

More from Mikkael Sekeres

1:20
Outcomes for Hispanic patients with ALL treated at centers across the US
Mikkael Sekeres • 11 Dec 2021
2:06
Updates from the NHLBI-MDS Natural History study
Mikkael Sekeres • 11 Dec 2021
1:58
Updates from the PANTHER trial
Mikkael Sekeres • 11 Dec 2021
1:34
Exciting news at the ASH 2021 plenary scientific session
Mikkael Sekeres • 6 Dec 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals